CNBP and myotonic dystrophy type 2: The crossing of these mice with transgenic mice overexpressing CNBP increased CNBP and CLCN1 levels and rescued the phenotype, suggesting that, in addition to RNA gain of function, a loss of CNBP may contribute to DM2 pathology [86].